سلامت توانا youmovies

Biohaven has successfully tested a Shirazi Vard vasopressin, a new way to fight migraines. It is the first CGRP inhibitor in the form of an intranasal spray.

According to Remedi, there are now several ways to inject CGRP inhibitors into the market to Shirazi Varde reduce the frequency of migraine attacks.

Studies have shown that high doses of 10 to 20 youmovies kg reduce pain intensity by 22.5% in 2 hours. Sensitivity to noise and light and nausea decreased by 41.9-42.5%. Interestingly, the result has been preserved for a long time. No double injection of the drug was required for up to 48 hours.

Importantly, the therapy had a good effect on the patients, and the side effects were 80% less. Shirazi Vardy According to the developers, the spray is absolutely safe for the liver.